|
|
cation transport
|
GO:0006812 |
399 |
0.404
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.366
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.336
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.302
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.290
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.246
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.245
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.237
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.230
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.224
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.222
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.214
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.183
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.182
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.153
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.146
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.142
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.137
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.137
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.135
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.131
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.129
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.128
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.126
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.122
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.122
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.121
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.120
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.109
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.108
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.108
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.107
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.107
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.104
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.100
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.100
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.100
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.099
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.097
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.097
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.095
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.095
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.094
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.094
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.094
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.093
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.093
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.092
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.092
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.091
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.091
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.091
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.090
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.089
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.088
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.086
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.086
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.084
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.083
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.083
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.083
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.082
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.082
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.081
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.079
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.079
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.078
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.078
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.078
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.076
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.075
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.074
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.074
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.073
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.073
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.072
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.071
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.071
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.071
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.071
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.070
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.070
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.069
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.069
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.068
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.068
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.067
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.067
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.067
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.067
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.066
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.065
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.065
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.065
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.065
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.065
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.064
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.063
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.063
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.062
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.062
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.062
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.061
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.061
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.061
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.060
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.060
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.060
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.060
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.060
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.060
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.060
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.060
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.059
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.059
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.059
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.059
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.059
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.058
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.058
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.058
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.056
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.056
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.056
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.056
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.056
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.055
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.055
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.055
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.054
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.053
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.053
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.053
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.053
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.053
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.052
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.052
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.052
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.052
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.052
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.052
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.052
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.052
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.052
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.052
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.052
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.051
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.051
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.051
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.051
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.051
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.050
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.050
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.050
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.050
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.050
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.050
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.050
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.050
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.049
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.049
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.048
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.048
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.048
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.048
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.048
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.047
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.047
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.047
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.047
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.047
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.047
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.047
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.047
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.047
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.047
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.046
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.046
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.046
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
28 |
0.046
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.046
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.045
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.045
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.045
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.045
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.045
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.045
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.045
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.044
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.044
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.044
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.044
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.044
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.044
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.044
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.044
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.044
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.044
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.043
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.043
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.043
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.043
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.043
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.043
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.043
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.043
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.043
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.043
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.043
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.043
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.042
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.042
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.042
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.042
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.042
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.042
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.042
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.042
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.042
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.042
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.042
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.042
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.041
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.041
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.041
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
25 |
0.041
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.041
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.041
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.041
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.040
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.040
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.040
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.040
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.040
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.040
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.040
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.040
|
|
|
|
interleukin 1 beta secretion
|
GO:0050702 |
16 |
0.040
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.040
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.040
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.040
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.040
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.040
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.039
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.039
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.039
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.039
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.039
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.039
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.039
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.039
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.039
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.039
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.039
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.038
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.038
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.038
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.038
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.038
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.038
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.038
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.038
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.038
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.038
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.038
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.038
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.038
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.037
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.037
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.037
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.037
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.037
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.037
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.037
|
|
|
|
male sex determination
|
GO:0030238 |
14 |
0.037
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.036
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.036
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.036
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.036
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.036
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.036
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.036
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.036
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.036
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.036
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.035
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.035
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.035
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.035
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.035
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.035
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.035
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.035
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.035
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.035
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.035
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.035
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.035
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.035
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.034
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.034
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.034
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.034
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.034
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.034
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.034
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.034
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.034
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.034
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.034
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.034
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.034
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.034
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.034
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.034
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.034
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.034
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.033
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.033
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.033
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.033
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.033
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.033
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.033
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.033
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.033
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.033
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.033
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.033
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.032
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.032
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.032
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.032
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.032
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.032
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.032
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.032
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.032
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.032
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.032
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.032
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.032
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.032
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.032
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.032
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.031
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.031
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.031
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.031
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.031
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.031
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.031
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.031
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.031
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.031
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.031
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.031
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.030
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.030
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.030
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.030
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.030
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.030
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.030
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.030
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.030
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.030
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.030
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.030
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.030
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.030
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.030
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.030
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.030
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.029
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.029
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.029
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.029
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.029
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.029
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.029
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.029
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.029
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.029
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.029
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.029
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.029
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.028
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.028
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.028
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.028
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.028
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.028
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.028
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.028
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.028
|
Mouse |
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.028
|
|
|
|
learning
|
GO:0007612 |
98 |
0.028
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.028
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.028
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.028
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.028
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.027
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.027
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.027
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.027
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.027
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.027
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.027
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.027
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.027
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.027
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.027
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.027
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.027
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.027
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.027
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.027
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.027
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.026
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.026
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.026
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.026
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.026
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.026
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.026
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.026
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.026
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.026
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.026
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.026
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.026
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.026
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.026
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.026
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.026
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.025
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.025
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.025
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.025
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.025
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.025
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.025
|
|
|
|
t helper 1 cell cytokine production
|
GO:0035744 |
1 |
0.025
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.025
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.025
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.025
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.025
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.025
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.024
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.024
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.024
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.024
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.024
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.024
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.024
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.024
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.024
|
|
|
|
anatomical structure regression
|
GO:0060033 |
9 |
0.024
|
|
|
|
positive regulation of cellular ph reduction
|
GO:0032849 |
2 |
0.024
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.024
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.024
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.024
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.024
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.024
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.024
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.024
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.024
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.024
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.024
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.024
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.024
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.024
|
|
|
|
left ventricular cardiac muscle tissue morphogenesis
|
GO:0003220 |
2 |
0.024
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.024
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.024
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.024
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.024
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.023
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.023
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.023
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.023
|
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
29 |
0.023
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.023
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.023
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.023
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.023
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.023
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.023
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.023
|
|
